Guess which ASX 300 healthcare share is lifting off on $25 million news

The ASX 300 healthcare share is grabbing investor interest on Thursday. Let's see why.

| More on:
Excited elderly woman on a swing.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Regis Healthcare's share price increased by 0.8% to $8.01 after announcing a divestment deal with Ozcare.
  • The company is selling two aged care facilities in Far North Queensland, aiming for a $25 million pre-tax gain recognised in FY 2026.
  • The divestment aligns with Regis' strategy to optimise its portfolio, while enhancing Ozcare’s presence.

S&P/ASX 300 Index (ASX: XKO) healthcare share Regis Healthcare Ltd (ASX: REG) is marching higher today.

Shares in the residential aged care provider closed yesterday trading for $7.95. In morning trade on Thursday, shares are changing hands for $8.01 apiece, up 0.8%.

For some context, the ASX 300 is up 0.4% at this same time.

Here's what's catching investor interest today.

ASX 300 healthcare share lifts on divestment news

The Regis Healthcare share price is pushing higher after the company announced that it has entered into agreements with not for profit aged care and health services provider Ozcare to sell two residential aged care homes.

The two assets are located at Ayr and Home Hill, both in Far North Queensland. Together, the two aged care facilities have 156 operational beds.

The ASX 300 healthcare stock expects the sale to bring in a one-off pre-tax gain on sale of approximately $25 million. The company said this gain will be recognised in its FY 2026 financial results.

Regis Healthcare expects the transaction to be complete by 1 March, subject to customary conditions.

What did management say?

Commenting on the divestment that looks to be boosting the ASX 300 healthcare share today, Regis managing director and CEO Linda Mellors said, "The divestment aligns with Regis' strategy to optimise its national portfolio and recycle capital to support investment in high-demand, premium locations where we can deliver the greatest impact."

Mellors continued:

We will work closely with Ozcare to ensure a smooth and respectful transition for residents, families, and staff, and to support continuity of care in Far North Queensland.

Ozcare CEO Kevin Mercer added:

We are delighted to welcome Ayr and Home Hill into the Ozcare family. These homes have a strong reputation for delivering quality care and supporting their local communities, which aligns perfectly with our mission to provide compassionate, person-centred services.

This acquisition strengthens our presence in North Queensland and ensures continuity of care for residents, families, and staff. We look forward to building on the excellent foundations laid by Regis and continuing to enhance the wellbeing of those we serve.

What's been happening with the ASX 300 healthcare share?

With today's intraday increase factored in, Regis Health Care shares are up 33% in 2025.

The ASX 300 healthcare share hit an all-time closing high of $9.22 on 19 September.

Shares then crashed 26.3% the following trading day, 22 September.

That sell-off followed news that the Australian government's residential aged care funding boost of 4.7% was less than Regis had expected, which comes amid increased staffing costs.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A male doctor and a woman in scrubs in the foreground smile.
Healthcare Shares

The next 3 years could be huge for this ASX healthcare stock. Here's why

Today's update has put this ASX healthcare stock back in the spotlight as investors reassess its long-term growth potential.

Read more »

A doctor sits with a patient and uses a pen to point to certain parts of her mammogram scan
Healthcare Shares

Top broker says this ASX small-cap healthcare stock could be set to double

This company is making significant clinical and commercial progress .

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

3 quality ASX healthcare shares worth buying now

Brokers think the tide is turning for these battling medical heavyweights.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Early success in battling Crohn's Disease has sent this ASX biotech's shares soaring

The early-stage results have been described as outstanding.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Why are 4DMedical shares in a trading halt today?

The company is looking to raise fresh capital.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX biotech's shares are up strongly on good news out of the US

The addressable market for this newly approved software is huge.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Which biotech company's shares have rocketed to a new high on good news?

A key US approval is great news for this company.

Read more »

Health professional working on his laptop.
Healthcare Shares

Insiders are buying. Can Pro Medicus shares finally turn the corner?

Insider buying puts Pro Medicus shares in focus after steep pullback, raising questions about downside risk and upside potential.

Read more »